Cargando…
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
CCR5 plays a central role in infectious disease, host defense, and cancer progression, thereby making it an ideal target for therapeutic development. Notably, CCR5 is the major HIV entry co-receptor, where its surface density correlates with HIV plasma viremia. The level of CCR5 receptor occupancy (...
Autores principales: | Chang, Xiao L., Wu, Helen L., Webb, Gabriela M., Tiwary, Meenakshi, Hughes, Colette, Reed, Jason S., Hwang, Joseph, Waytashek, Courtney, Boyle, Carla, Pessoa, Cleiton, Sylwester, Andrew W., Morrow, David, Belica, Karina, Fischer, Miranda, Kelly, Scott, Pourhassan, Nader, Bochart, Rachele M., Smedley, Jeremy, Recknor, Christopher P., Hansen, Scott G., Sacha, Jonah B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640501/ https://www.ncbi.nlm.nih.gov/pubmed/34868084 http://dx.doi.org/10.3389/fimmu.2021.794638 |
Ejemplares similares
-
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
por: Chang, Xiao L., et al.
Publicado: (2022) -
LERONLIMAB AND THE ROLE OF CCR5 SUPRESSION IN COVID-19 TREATMENT
por: BJORK, SARAH, et al.
Publicado: (2021) -
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab
por: Agresti, Nicholas, et al.
Publicado: (2021) -
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
por: Chang, Xiao L., et al.
Publicado: (2021) -
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes
por: Connolly, Kelli A., et al.
Publicado: (2016)